U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924021) titled 'Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)' on April 04.
Brief Summary: 1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial Intelligence (AI) based screening tool for AMD.
Study Start Date: April, 2025
Study Type: OBSERVATIONAL
Condition:
Age-Related Macular Degeneration
Intervention:
OTHER: Retinal Imaging
Eligible participants will undergo one retinal imagin...